27 related articles for article (PubMed ID: 2421894)
1. Response of patients in phase II studies of chemotherapy in ovarian cancer: implications for patient treatment and the design of phase II trials.
Blackledge G; Lawton F; Redman C; Kelly K
Br J Cancer; 1989 Apr; 59(4):650-3. PubMed ID: 2713253
[TBL] [Abstract][Full Text] [Related]
2. Phase II study of combination 4'-epidoxorubicin and mitomycin C in recurrent epithelial ovarian cancer.
Redman C; Lawton F; Stuart N; O'Brien M; Buxton J; Mould J; Chetiyawardana A; Crawford M; Patterson M; Sykes V
Cancer Chemother Pharmacol; 1989; 23(1):51-3. PubMed ID: 2491794
[TBL] [Abstract][Full Text] [Related]
3. Detoxifying enzymes in human ovarian tissues: comparison of normal and tumor tissues and effects of chemotherapy.
Djuric Z; Malviya VK; Deppe G; Malone JM; McGunagle DL; Heilbrun LK; Reading BA; Lawrence WD
J Cancer Res Clin Oncol; 1990; 116(4):379-83. PubMed ID: 2391358
[TBL] [Abstract][Full Text] [Related]
4. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
Wadler S; Yeap B; Vogl S; Carbone P
Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
[TBL] [Abstract][Full Text] [Related]
5. Treatment of malignant germ cell tumors of the ovary with cisplatin, vinblastine, and bleomycin (PVB).
Vriesendorp R; Aalders JG; Sleijfer DT; Willemse PH; Bouma J; Mulder NH
Cancer Treat Rep; 1984 May; 68(5):779-81. PubMed ID: 6202407
[TBL] [Abstract][Full Text] [Related]
6. Cisplatin, vinblastine, and bleomycin combination chemotherapy in endodermal sinus tumor of the ovary.
Sessa C; Bonazzi C; Landoni F; Pecorelli S; Sartori E; Mangioni C
Obstet Gynecol; 1987 Aug; 70(2):220-4. PubMed ID: 2439966
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin plus etoposide as second-line treatment in advanced ovarian carcinoma.
De Lena M; Lorusso V; Romito S
Cancer Treat Rep; 1986 Jul; 70(7):893-5. PubMed ID: 3719581
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of vinblastine and bleomycin in advanced ovarian cancer.
Osborne RJ; Harvey VJ; Slevin ML; Shepherd JH; Williams CJ
Cancer Treat Rep; 1987 Mar; 71(3):335-6. PubMed ID: 2434227
[No Abstract] [Full Text] [Related]
9. Combination of bleomycin and mitomycin after failure of cisplatin and alkylating agent therapy in epithelial ovarian cancer.
Lawton FG; Perren TJ; Luesley DM; Meanwell CA; Chan KK; Mould JJ; Blackledge G
Cancer Treat Rep; 1986 Apr; 70(4):525-6. PubMed ID: 2421894
[No Abstract] [Full Text] [Related]
10. Good pregnancy outcome after prenatal exposure to bleomycin, etoposide and cisplatin for ovarian immature teratoma: a case report and literature review.
Karimi Zarchi M; Behtash N; Modares Gilani M
Arch Gynecol Obstet; 2008 Jan; 277(1):75-8. PubMed ID: 17653741
[TBL] [Abstract][Full Text] [Related]
11. [Gynecologic cancer-evidenced based chemotherapy].
Ochiai K
Gan To Kagaku Ryoho; 2000 Jan; 27(1):52-7. PubMed ID: 10660733
[TBL] [Abstract][Full Text] [Related]
12. [Early diagnosis and effective treatment of ovarian cancer].
Sawada M; Matsui Y; Okudaira Y
Gan To Kagaku Ryoho; 1983 May; 10(5):1251-8. PubMed ID: 6191676
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
